Prophylactic versus reactive percutaneous endoscopic gastrostomy in oropharyngeal squamous cell carcinoma patients undergoing radical radiotherapy
Authors:
- 23 August 2021
- journal article
- research article
- Published by Wiley in Anz Journal of Surgery
- Vol. 91 (12) , 2720-2725
Abstract
Background: Radiotherapy (RT) for oropharyngeal squamous cell cancer (OPSCC) is associated with malnutrition due to treatment‐related mucositis and dysphagia. While percutaneous endoscopic gastrostomy (PEG) feeding can improve nutrition, it has acute and late complications, including dependence on PEG feeding. We retrospectively evaluated patient outcomes by whether gastrostomy placement was prophylactic (P‐G) or reactive to RT complications (R‐G).Methods: Retrospective analysis of OPSCC patients undergoing curative‐intent RT at Waikato Hospital between 2010 and 2015.Results: Of 103 OPSCC patients treated with RT (+/− chemotherapy) 21 had P‐G, 15 had R‐G and 67 had none (No‐G). P‐G patients were significantly more likely to be female, older, have higher tumour stage and receive bilateral RT (all p < 0.05). P‐G and No‐G patients had similar rates and duration of hospital admission for complications during treatment, but both were significantly less than in R‐G patients (admission rates 52.3%, 49.3% and 86.7%, and mean length of stay 3.5, 3.3 and 11.9 days, respectively; p < 0.001). R‐G patients also had greater RT treatment delays than P‐G or No‐G patients (mean 1.1, 0.7 and 0.4 days, respectively, p < 0.05). No significant differences were noted between groups in PEG dependence or weight change during, or 1, 3 or 6 months after, RT. Weight loss was not significantly different with P‐G than R‐G despite more frequent use of bilateral RT fields in the former group.Conclusions: P‐G placement affords shorter and less frequent hospital admissions than R‐G during RT for OPSCC, with no increased complications or gastrostomy‐dependence rates.Keywords
This publication has 19 references indexed in Scilit:
- The Effect of Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement on Swallowing and Swallow-Related Outcomes in Patients Undergoing Radiotherapy for Head and Neck Cancer: A Systematic ReviewDysphagia, 2015
- Percutaneous endoscopic gastrostomy tube dependence following chemoradiation in head and neck cancer patientsThe Laryngoscope, 2015
- Prophylactic versus Reactive PEG Tube Placement in Head and Neck CancerOtolaryngology–Head and Neck Surgery, 2013
- Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapyHead & Neck, 2013
- Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity‐modulated radiotherapy with concurrent chemotherapyCancer, 2012
- Outcomes of Percutaneous Endoscopic Gastrostomy Tube Placement Using a T‐Fastener Gastropexy Device in Head and Neck and Esophageal Cancer PatientsNutrition in Clinical Practice, 2010
- Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiationHead & Neck, 2009
- Radiation Treatment Breaks and Ulcerative Mucositis in Head and Neck CancerThe Oncologist, 2008
- Percutaneous endoscopic gastrostomy (PEG) - a long-term follow-up study in head and neck cancer patientsClinical Otolaryngology, 2004
- ‘Push’ versus ‘pull’ percutaneous endoscopic gastrostomy tube placement in patients with advanced head and neck cancerThe Laryngoscope, 2003